US labelling rule for injectable drugs aims to reduce risk of death
This article was originally published in Scrip
Executive Summary
The US Pharmacopeial Convention has issued new labelling requirements for injectable drugs that will standardise the information permitted on the highly visible area of vials to only cautionary statements intended to prevent imminent life-threatening situations.